Filing Details
- Accession Number:
- 0000950170-25-048775
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-01 18:44:41
- Reporting Period:
- 2025-03-28
- Filing Date:
- 2025-04-01
- Accepted Time:
- 2025-04-01 18:44:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 728387 | Perspective Therapeutics Inc. | CATX | Surgical & Medical Instruments & Apparatus (3841) | 411458152 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1535289 | M. Johan Spoor | C/O Perspective Therapeutics, Inc. 2401 Elliott Avenue, Suite 320 Seattle WA 98121 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-28 | 22,026 | $2.24 | 59,383 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-28 | 4,650 | $2.21 | 4,650 | No | 4 | P | Indirect | By Child #1 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Indirect | By Child #1 |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,400 | Indirect | By IRA of Reporting Person |
| Common Stock | 12,600 | Indirect | By IRA of Spouse |
| Common Stock | 1,000 | Indirect | By Spouse |
| Common Stock | 4,650 | Indirect | By Child #2 |
Footnotes
- The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.1900 to $2.3000, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price in the transaction described in this footnote.
- Previous Form 4s filed on behalf of the Reporting Person under-reported the Reporting Person's holdings by 1,100 shares of Common Stock. The amount reported in this Form 4 reflects the correct amount.
- The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.1900 to $2.2450, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price in the transaction described in this footnote.
- Previous Form 4s filed on behalf of the Reporting Person reported these share as being held by the Reporting Person's child. The information in this Form 4 reflects the correct ownership structure of these shares.
- These shares are held in a Uniform Transfers to Minors Act account for which the Reporting Person's spouse serves as the custodian. The purchases were made in November 2022 and December 2023 and were not previously reported due to an administrative error.
Billionaire Hedge Funds
